Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice

  • Jung Min Han,

    Affiliations Center for Medicinal Protein Network and Systems Biology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Republic of Korea

  • Nam Hoon Kwon,

    Affiliation Center for Medicinal Protein Network and Systems Biology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea

  • Jin Young Lee,

    Affiliation Center for Medicinal Protein Network and Systems Biology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea

  • Seung Jae Jeong,

    Affiliation Center for Medicinal Protein Network and Systems Biology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea

  • Hee Jung Jung,

    Affiliation Cancer & Infectious Disease Research Center, Bio-Organic Science Division, Korea Research Institute of Chemical Technology, Dae Jeon, Republic of Korea

  • Hyeong Rae Kim,

    Affiliation Cancer & Infectious Disease Research Center, Bio-Organic Science Division, Korea Research Institute of Chemical Technology, Dae Jeon, Republic of Korea

  • Zihai Li,

    Affiliation Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, Connecticut, United States of America

  • Sunghoon Kim

    sungkim@snu.ac.kr

    Affiliations Center for Medicinal Protein Network and Systems Biology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Suwon, Republic of Korea

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.